Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?
Reviva Pharmaceuticals Ownership Summary
Reviva Pharmaceuticals is owned by 11.19% institutional investors, 4.23% insiders, and 84.57% retail investors. Millennium management is the largest institutional shareholder, holding 5.34% of RVPH shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.50% of its assets in Reviva Pharmaceuticals shares.
RVPH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Reviva Pharmaceuticals | 11.19% | 4.23% | 84.57% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Millennium management | 1.80M | 5.34% | $3.27M |
| Diadema partners lp | 2.51M | 5.03% | $924.05K |
| Vanguard group | 3.20M | 4.40% | $892.13K |
| Geode capital management | 1.05M | 1.44% | $292.68K |
| Jane street group | 894.75K | 1.23% | $249.64K |
| Persistent asset partners | 593.90K | 1.19% | $218.91K |
| Susquehanna group, llp | 202.01K | 0.60% | $365.64K |
| State street | 383.20K | 0.53% | $106.91M |
| Blackrock funding, inc. /de | 371.66K | 0.51% | $103.69K |
| Ubs group | 359.45K | 0.49% | $100.29K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Diadema partners lp | 2.51M | 0.24% | $924.05K |
| Persistent asset partners | 593.90K | 0.15% | $218.91K |
| Emc capital management | 128.41K | 0.03% | $49.00K |
| Pale fire capital se | 25.00K | 0.00% | $32.00K |
| Xtx topco | 100.40K | 0.00% | $37.01K |
| Nri wealth management lc | 11.38K | 0.00% | $3.17K |
| Millennium management | 1.80M | 0.00% | $3.27M |
| Cutler investment counsel | 33.50K | 0.00% | $9.35K |
| Flagship harbor advisors | 12.53K | 0.00% | $3.50K |
| Tower research capital llc (trc) | 22.42K | 0.00% | $8.26K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 3.20M | - | 1.27M |
| Jane street group | 894.75K | - | 666.62K |
| Geode capital management | 1.05M | - | 489.71K |
| Ubs group | 359.45K | - | 359.45K |
| Morgan stanley | 337.31K | - | 333.19K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -2.69M |
| Heights capital management | - | - | -1.83M |
| 683 capital management | - | - | -1.00M |
| Woodline partners lp | - | - | -684.80K |
| Parkman healthcare partners | - | - | -514.27K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Group one trading | 62.37K | - | 62.37K | $17.40K |
| Cetera investment advisers | 60.00K | - | 60.00K | $22.12K |
| Cutler investment counsel | 33.50K | 0.00% | 33.50K | $9.35K |
| Hrt financial lp | 31.11K | - | 31.11K | $8.00K |
| Citigroup | 18.39K | - | 18.39K | $5.13K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -50.00 |
| Jpmorgan chase | -235.00 |
| Tradewinds capital management | -250.00 |
| Advisor group | -250.00 |
| Wolverine asset management | -442.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | -19.15% | 8,136,283 | -14.17% | 11 | 3.10% | 20 | 11.11% | 7 | -36.36% |
| Sep 30, 2025 | 43 | -12.24% | 9,324,158 | -34.68% | 18 | 1.01% | 17 | -22.73% | 10 | 11.11% |
| Jun 30, 2025 | 51 | -3.77% | 14,278,367 | 98.90% | 43 | 9.18% | 22 | -21.43% | 9 | - |
| Mar 31, 2025 | 53 | 8.16% | 7,348,669 | -4.96% | 22 | 4.24% | 29 | -3.33% | 9 | 12.50% |
| Dec 31, 2024 | 49 | 32.43% | 7,732,309 | -22.27% | 22 | 2.64% | 30 | 100.00% | 8 | -11.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 700.44K | 1.50% | - |
| Vanguard Total Stock Mkt Idx Inv | 59.61K | 0.47% | -1.13M |
| Vanguard Institutional Extnd Mkt Idx Tr | 57.96K | 0.45% | -1.10M |
| Blackrock Extended Mkt Fund CF | 18.46K | 0.31% | -350.83K |
| Abante Quant Value FI | 345.41K | 0.29% | -264.31K |
| Fidelity Extended Market Index | 548.46K | 0.21% | -1.99K |
| Extended Equity Market Fund K | 27.25K | 0.21% | -289.49K |
| BlackRock Extended Equity Market K | 48.10K | 0.15% | -20.00 |
| Extended Equity Market Fund B | 369.30K | 0.14% | 314.11K |
| Extended Equity Market Fund E | 369.30K | 0.14% | 314.11K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 18, 2022 | Patel Purav | - | Buy | $14.07K |
| Sep 30, 2022 | Narayan Prabhu | Chief Financial Officer | Buy | $83.00K |
| Sep 08, 2022 | VEDANTA PARTNERS, LLC | - | Buy | $86.96 |
| Sep 08, 2022 | VEDANTA PARTNERS, LLC | - | Buy | $51.38 |
| Sep 08, 2022 | VEDANTA PARTNERS, LLC | - | Buy | $2.09M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
RVPH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools